miltefosine has been researched along with glycolipids in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geilen, CC; Orfanos, CE; Wieder, T | 1 |
| Carrasco, MP; Jiménez-López, JM; Marco, C; Segovia, JL | 1 |
| Carrasco, MP; Jiménez-López, JM; Marco, C; Ríos-Marco, P; Segovia, JL | 1 |
3 other study(ies) available for miltefosine and glycolipids
| Article | Year |
|---|---|
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.
Topics: Antineoplastic Agents; Apoptosis; Carboxylic Acids; Cell Division; Cell Line; Ceramides; Fumonisins; Phosphatidylcholines; Phosphorylcholine; Sphingomyelins | 1998 |
Hexadecylphosphocholine disrupts cholesterol homeostasis and induces the accumulation of free cholesterol in HepG2 tumour cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Ceramides; Chlorocebus aethiops; Cholesterol; Cholesterol Esters; DNA Fragmentation; Homeostasis; Humans; Phosphorylcholine; Sphingomyelins; Vero Cells | 2006 |
Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells.
Topics: Biological Transport; Cell Line, Tumor; Cell Membrane; Ceramides; Cholesterol; Cholesterol Esters; Cholesterol, LDL; Endoplasmic Reticulum; Humans; Lysosomes; Phosphorylcholine; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2009 |